Pulmatrix
IPOPublic · Lexington, United States · Founded 2003 · $54.2M raised
- Headquarters
- Lexington, Massachusetts
- Employees
- 11–50
- Founded
- 2003
- Business Model
- B2B
- Website
- pulmatrix.com
- Total Funding
- $54.2M
- Last Round
- $10.0M Private EquityJun 2015
- Rounds
- 4
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 2 investors for this company. The full record is or through the API.
About
Pulmatrix is a clinical-stage biotech developing inhaled therapeutics using its iSPERSE dry powder delivery platform for respiratory and systemic diseases.
Summary
Pulmatrix is a Biotech company based in Lexington, United States, founded in 2003. It has raised $54.2M in total across 4 rounds, most recently a $10.0M Private Equity round in Jun 2015. Investors include ARCH Venture Partners and Polaris Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jun 2015
Sign up to see all 5 events
Funding: Series A through Private Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pulmatrix"><img src="https://indexed.vc/api/badge/company/pulmatrix" alt="Pulmatrix on Indexed.vc" width="260" height="76" /></a>